跳至主要内容
临床试验/NCT07479251
NCT07479251尚未招募不适用

Glycaemic Index Measurement of an Oral Nutritional Supplement With Biomarker Assessment and Lifestyle Monitoring in Healthy Participants

Fresenius Kabi0 个研究点目标入组 30 人开始时间: 2026年3月1日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
主要终点
Glycaemic Index (GI) of ONS

研究概览

简要总结

This clinical trial evaluates the postprandial glycaemic response to an Oral Nutritional Supplement (ONS), a Food for Special Medical Purposes (FSMP), in healthy adults. The study uses a crossover design comparing the ONS to the reference product glucose.

Each participant will consume both test and reference products on three separate occasions each, overall on six test days.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Aged ≥18 and ≤60 years, adult healthy Caucasian or Chinese participants
  • Stable body weight within the Body Mass Index between 18.5 kg/m2 and 27.9 kg/m2 (inclusive)
  • Glycated hemoglobin < 6%/< 42 mmol/mol

排除标准

  • Pregnant or lactating,
  • Body fat percentage exceeding 30%,
  • Known history of metabolic diseases or diabetes mellitus,
  • Major medical or surgical event requiring hospitalization within the preceding 3 months
  • Medical condition(s) or medication(s) or herbal effects known to affect glucose regulation, tolerance or appetite and/or which influence digestion and absorption of nutrients (excluding oral contraceptives),
  • Use of steroids, protease inhibitors, amphetamines or antipsychotics

结局指标

主要结局

Glycaemic Index (GI) of ONS

时间窗: Blood samples will be obtained at -5, 0, 15, 30, 45, 60, 90, and 120 minutes.

Three GIs for each repeated test of the ONS (based on capillary blood glucose) and their average GI (mean value) will be calculated as per ISO 26642.

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

相似试验